Image : Purely Representational Purpose Only
India’s pharmaceutical exports stood at over $28 billion up to February in the last financial year, registering a growth of more than 5 per cent compared to the same period previous year, a top official said .
K Raja Bhanu, director general of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), said the sector, currently valued at around $60 billion, is projected to grow to $130 billion by 2030.
“Despite global challenges, pharmaceutical exports have been among the few sectors to maintain growth momentum.
Exports during April–February FY26 stood at $28.29 billion, reflecting a growth of 5.6 per cent compared to the same period in FY25, led by formulations, biologicals, vaccines and AYUSH products,” he said, addressing the inaugural session of the ‘Chintan Shivir: Scaling Up Pharma Exports’.
Bhanu added that exports reached $30.47 billion in FY2024–25, marking a year-on-year growth of 9.4 per cent despite global pricing pressures and trade volatility.
Pharmexcil Chairman Namit Joshi said India is likely to end the current financial year at levels similar to FY25.
